AzTrials
AzTrials

Bipolar DisorderNCT05936983

Comparison of Physical Fitness, Physical Activity Level in Patients With Bipolar Disorder and Schizophrenia

An observational study of Bipolar Disorder and Schizophrenia, run by Yeditepe University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

According to the World Health Organization; Bipolar disorder ranks in the top 20 causes of disability among all medical conditions and 6th among mental disorders worldwide. Bipolar disorder is noted as a serious mental illness involving emotional ups and downs. Read more about this study

Who is it for?
Ages 30 to 55 years
Conditions the study is for
Bipolar Disorder, Schizophrenia
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 Jun 2023to 20 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 55 years
  • All sexes
  • Adult

Study population: patients with Bipolar disorder and schizophrenia come to the community mental health center regularly

Who may be able to join

  • Individuals diagnosed with bipolar disorder and schizophrenia by a physician according to DSM-5 criteria
  • Individuals with bipolar and schizophrenia between the ages of 30-55
  • Patients without any other accompanying psychiatric disorder
  • Patients who can communicate
  • Patients who agreed to participate in this study and gave informed consent

Who cannot join

  • Patients with a psychiatric diagnosis other than bipolar and schizophrenia.
  • Pregnancy condition
  • Those who did not consent to participate in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Yeditepe University

    Istanbul

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Physical Fitness, Physical Activity Level, Depression and Quality of Life in Patients With Bipolar Disorder and Schizophrenia With Healthy Controls

According to the World Health Organization; Bipolar disorder ranks in the top 20 causes of disability among all medical conditions and 6th among mental disorders worldwide. Bipolar disorder is noted as a serious mental illness involving emotional ups and downs.

Read the detailed description

Schizophrenia is a chronic mental disorder characterized by the appearance of both positive symptoms such as hallucinations and delusions and negative symptoms such as apathy and withdrawal, repetition of cognitive skills, and disorganization. In this study, it was aimed to compare physical fitness, physical activity level, depression and quality of life in bipolar disoder and schizophrenic patients with healthy individuals.

Medical subject headings
Bipolar Disorder, Schizophrenia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05936983
Study groupRoleWhat they receive
Patients with Bipolar disorderParticipants will be asked to fill out a structured questionnaire containing their sociodemographic characteristics. Then, Anthropometric Measurements, Eurofit test battery, Rapid Depressive Symptom Inventory-Self-Report Form and International physical activity questionnaire will be applied respectively.
Patients with Schizophrenia groupParticipants will be asked to fill out a structured questionnaire containing their sociodemographic characteristics. Then, Anthropometric Measurements, Eurofit test battery, Rapid Depressive Symptom Inventory-Self-Report Form and International physical activity questionnaire will be applied respectively.
Healthy groupParticipants will be asked to fill out a structured questionnaire containing their sociodemographic characteristics. Then, Anthropometric Measurements, Eurofit test battery, Rapid Depressive Symptom Inventory-Self-Report Form and International physical activity questionnaire will be applied respectively.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Waist measurement - Antropometric Measurements

    Waist measurement is measured from the narrowest area between the subcostal region and the iliac crest.

    Measured: 4 weeks

  2. Abdomen measurement - Antropometric Measurements

    Abdomen measurement is measured at the level of the umbilicus without compression of the tissues.

    Measured: 4 weeks

  3. The hip measurement - Antropometric Measurements

    The hip measurement is measured from the thickest part of the hip area.

    Measured: 4 weeks

  4. Eurofit Test Battery

    A test-retest design was applied to test the reproducibility of several Eurofit test battery items. Supervision and measurement of the Eurofit test battery was performed by one trained mental health physical therapist following a standardized procedure. The Eurofit test battery included seven items and involved the assessment of the following measures: whole body balance, speed of limb movement, flexibility, explosive strength, static strength, abdominal muscular endurance and running speed.

    Measured: 4 weeks

  5. Quick Inventory of Depressive Symptomatology (QIDS-SR16) scale

    QIDS-SR consists of 16 items each ranging from 0 to 3. It is scored by summing the highest response in each of a set of questions relating to sleep, weight and psychomotor symptoms and then adding the remaining items

    Measured: 4 weeks

  6. International Physical Activity Questionnaire

    The IPAQ questionnaires list activities and request estimates of durations and frequencies for each activity engaged in over the past week. Durations are multiplied by known METs per activity and the results for all items are summed for the overall physical activity score. Scores for walking and for moderate and vigorous activities are sums of corresponding item scores. A sitting question is not included in physical activity score.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2023
  2. Study start2 Jun 2023
  3. Primary completion15 Jun 2023
  4. Study completion20 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05936983
Sponsor's protocol ID
2023/514/247/4
Status last verified
Jun 2023
First submitted
31 May 2023
Last updated
10 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bipolar Disorder and Schizophrenia, run by Yeditepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Waist measurement - Antropometric Measurements (time frame: 4 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in